CHIEF MED/SCI OFCR EVP ADVTECH · iRhythm Holdings, Inc. · Common Stock
Grant or award — administrative, little informational value
No reported dollar value · 36.2% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 37 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Open-market sale | SELL | $884K 7,093 sh | Aug 11, 2026 traded Aug 10, 2026 | |
| 13 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Grant or award | A | — 13.6K sh | Aug 11, 2026 traded Aug 7, 2026 | |
| 41 | Patterson ChadCHIEF COMM & PRODUCT OFFICER | Open-market sale | SELL | $884K 7,093 sh | Aug 11, 2026 traded Aug 10, 2026 | |
| 17 | Patterson ChadCHIEF COMM & PRODUCT OFFICER | Grant or award | A | — 13.6K sh | Aug 11, 2026 traded Aug 7, 2026 | |
| 41 | Shrishrimal SumiEVP, Chief Risk Officer | Open-market sale | SELL | $670K 5,372 sh | Aug 11, 2026 traded Aug 10, 2026 | |
| 17 | Shrishrimal SumiEVP, Chief Risk Officer | Grant or award | A | — 9,706 sh | Aug 11, 2026 traded Aug 7, 2026 | |
| 28 | Freeman Sean ClintonEVP, Strategy & Corp Devt | Open-market sale | SELL | $114K 918 sh | Jul 6, 2026 traded Jul 2, 2026 | |
| 9 | Freeman Sean ClintonEVP, Strategy & Corp Devt | Grant or award | A | $26K 273 sh | Jun 1, 2026 traded May 29, 2026 | |
| 9 | Patterson ChadCHIEF COMM & PRODUCT OFFICER | Grant or award | A | $17K 177 sh | Jun 1, 2026 traded May 29, 2026 | |
| 5 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Grant or award | A | $13K 137 sh | Jun 1, 2026 traded May 29, 2026 | |
| 27 | Patten Jason HDirector | Grant or award | A | — 2,218 sh | Mar 19, 2026 traded Mar 12, 2026 | |
| 21 | Freeman Sean ClintonEVP, Strategy & Corp Devt | Grant or award | A | — 7,525 sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 13 | Smith MervinEVP Strategic Business Ops | Grant or award | A | — 6,689 sh | Feb 27, 2026 traded Feb 25, 2026 | |
| 21 | Smith MervinEVP Strategic Business Ops | Grant or award | A | — 9,210 sh | Feb 26, 2026 traded Feb 24, 2026 | |
| 21 | Rosenbaum Marc WadeChief Accounting Officer | Grant or award | A | — 9,210 sh | Feb 26, 2026 traded Feb 24, 2026 | |
| 41 | Rosenbaum Marc WadeChief Accounting Officer | Open-market sale | SELL | $650K 4,797 sh | Feb 26, 2026 traded Feb 25, 2026 | |
| 37 | Smith MervinEVP Strategic Business Ops | Open-market sale | SELL | $547K 4,041 sh | Feb 26, 2026 traded Feb 25, 2026 | |
| 44 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Open-market sale | SELL | $1.06M 7,804 sh | Feb 26, 2026 traded Feb 25, 2026 | |
| 15 | Rosenbaum Marc WadeChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $39K 280 sh | Feb 25, 2026 traded Feb 24, 2026 | |
| 18 | Smith MervinEVP Strategic Business Ops | Open-market sale · 10b5-1 plan | SELL | $103K 732 sh | Feb 25, 2026 traded Feb 24, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Turakhia Minang filed this Form 4 reporting a grant or award of IRTC on Feb 24, 2026. It became public on Feb 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.